This is a case-based activity that includes discussion of a 65 year old healthy man dx SP RRP revealing pT3a, Gleason 4+3= 7 and tertiary of 5, pre-op PSA 2.26 ng/ml. Pre treatment bone scan and CT negative for metastatic disease. Post-OP, PSA became undetectable until ~3.3 yrs later when it measured 0.08 ng/ml. Along with the patient case, there is a discussion board on ASCO Connection, where users can post comments/questions to each other and to the faculty. At the end of this course you should be able to:
- Review and evaluate recent data that should be considered in the management of men with metastatic prostate cancer.
- Summarize contemporary treatment paradigms of men with metastatic prostate cancer
- Analyze the mechanisms of action and clinical application of the current armamentarium for men with metastatic prostate cancer
- Explain the current clinical states model of prostate cancer
Medical Knowledge (ACGME, AAPA)
Health Promotion, Health Protection, Disease Prevention, and Treatment (ONS)
Note: This course is now accessible through mobile devices as well as personal computers